Diabetes & Metabolism
Perioperative management of SGLT2 inhibitors: balancing euglycaemic ketoacidosis risk and cardiorenal benefits
ReviewInterventions
The paper
Shanghai Jiao Tong University
Diabetes & Metabolism, 18 Sep 2026
Related
Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
